Clinical Trial Update: Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study from Oregon Health and Science University assessing the immunogenicity of the Yellow Fever vaccine 17D in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• Yellow fever vaccine 17D (YF-Vax) (Yellow fever vaccine live attenuated 17D strain)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Yellow Fever, Immunization; Infection | Phase 1, Phase 2 | Status: RECRUITING